Form 8-K - Current report:
SEC Accession No. 0001100682-25-000023
Filing Date
2025-05-23
Accepted
2025-05-23 16:12:28
Documents
12
Period of Report
2025-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K crl-20250520.htm   iXBRL 8-K 43115
  Complete submission text file 0001100682-25-000023.txt   159841

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crl-20250520.xsd EX-101.SCH 1780
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crl-20250520_lab.xml EX-101.LAB 21880
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crl-20250520_pre.xml EX-101.PRE 12511
14 EXTRACTED XBRL INSTANCE DOCUMENT crl-20250520_htm.xml XML 2729
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1227
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 25982348
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)